Altimmune, Inc. — Director's Dealing 2024

Oct 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2024-09-26

Reporting Person: Sohn Catherine A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-26	Stock Options (option to buy)	$6.81	A	34900	Acquired	2034-09-26	Common Stock, par value $0.0001 (34900)	Direct

Footnotes

F1: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date.